Role of cannabinoids in chronic liver diseases
Open Access
- 1 January 2008
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 14 (40) , 6109-6114
Abstract
Role of cannabinoids in chronic liver diseasesKeywords
This publication has 44 references indexed in Scilit:
- Endocannabinoids acting at CB1receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic ratsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre‐disposition pending between fiction and realityJournal of Cellular and Molecular Medicine, 2007
- Role of the nitric oxide pathway and the endocannabinoid system in neurogenic relaxation of corpus cavernosum from biliary cirrhotic ratsBritish Journal of Pharmacology, 2007
- Rimonabant: a selective blocker of the cannabinoid CB1 receptors for the management of obesity, smoking cessation and cardiometabolic risk factorsExpert Opinion on Investigational Drugs, 2006
- Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significanceProstaglandins, Leukotrienes and Essential Fatty Acids, 2002
- CIRCULATING TRANSFORMING GROWTH FACTOR β1AS AN INDICATOR OF HEPATIC FUNCTION IMPAIRMENT IN LIVER CIRRHOSISCytokine, 2000
- Molecular characterization of a peripheral receptor for cannabinoidsNature, 1993
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- Structure of a cannabinoid receptor and functional expression of the cloned cDNANature, 1990
- Isolation, Structure, and Partial Synthesis of an Active Constituent of HashishJournal of the American Chemical Society, 1964